Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:04:43 GMT 2025
by
admin
on
Mon Mar 31 22:04:43 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | MOUSE CHIMERIC |
| Sequence Type | COMPLETE |
| Record UNII |
YB2EWE6139
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1742
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
||
|
FDA ORPHAN DRUG |
504715
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10244
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
Carotuximab
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
EF-64
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
DB06322
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109321
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
C74010
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
100000175052
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
YB2EWE6139
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY | |||
|
1268714-50-6
Created by
admin on Mon Mar 31 22:04:43 GMT 2025 , Edited by admin on Mon Mar 31 22:04:43 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_98 |
| 1_145 | 1_201 |
| 1_262 | 1_322 |
| 1_368 | 1_426 |
| 2_22 | 2_98 |
| 2_145 | 2_201 |
| 2_262 | 2_322 |
| 2_368 | 2_426 |
| 1_221 | 3_213 |
| 2_221 | 4_213 |
| 1_227 | 2_227 |
| 1_230 | 2_230 |
| 3_23 | 3_87 |
| 3_133 | 3_193 |
| 4_23 | 4_87 |
| 4_133 | 4_193 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_298 |
| N | 2_298 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|